Old Web
English
Sign In
Acemap
>
Paper
>
F5. CIRCULATING IGFBP-2 LEVELS REVEAL ATHEROGENIC METABOLIC RISK IN SCHIZOPHRENIC PATIENTS USING ATYPICAL ANTIPSYCHOTICS
F5. CIRCULATING IGFBP-2 LEVELS REVEAL ATHEROGENIC METABOLIC RISK IN SCHIZOPHRENIC PATIENTS USING ATYPICAL ANTIPSYCHOTICS
2019
Marc-André Nolin
Chloé Rauzier
Natalie Alméras
Jean-Pierre Després
Marc-André Roy
Roch-Hugo Bouchard
Marie-France Demers
Frédéric Picard
Keywords:
Psychology
Oncology
Psychiatry
Internal medicine
metabolic risk
Bioinformatics
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]